Dianthus Therapeutics | MGTA - PE Price to Earnings


Dianthus Therapeutics reported 3.8 in PE Price to Earnings for its fiscal quarter ending in September of 2024.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Celltrion 67.83 17.74 Dec/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
IQVIA Holdings 19.37 7.21 Mar/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 235 224.49 Sep/2025
Organon & Co 3.75 0.87 Dec/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 19.13 1.72 Mar/2026
Qiagen NV 20.54 0.1 Dec/2025
Revvity 30.79 19.08 Mar/2026
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 14.61 4.21 Mar/2026
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026